• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤的骨代谢参数及其与细胞遗传学的关系。

Bone metabolism parameters and their relation to cytogenetics in multiple myeloma.

机构信息

Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.

Department of Clinical Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.

出版信息

Eur J Haematol. 2022 Jul;109(1):75-82. doi: 10.1111/ejh.13771. Epub 2022 Mar 24.

DOI:10.1111/ejh.13771
PMID:35306691
Abstract

OBJECTIVES

Our aim was to correlate serum levels of selected markers of bone metabolism and bone marrow microenvironment to cytogenetic changes in patients with multiple myeloma (MM).

METHODS

We assed cytogenetic changes in 308 patients and correlated them with the following levels of bone marrow metabolism: thymidine kinase (TK), β2-microglobulin (b-2-m), Dickkopf-1 protein (DKK-1), C-terminal telopeptide collagen-I (ICTP), N-terminal propeptide of type I procollagen (PINP), receptor for interleukin 6 (rIL-6), vascular cell adhesive molecule-1 (VCAM), soluble intercellular adhesion molecule-1, osteoprotegerin (OPG), hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), syndecan-1 (SYN-1) and Fas antigen.

RESULT

Individuals with delRB1 had lower levels of OPG (M = 7.39 vs. 5.46 pmol/L, p = .025) and VEGF (M = 304 vs. 196 pg/ml; p = .036). t(14;16) was associated with higher β2m levels (M = 7.59 vs. 4.13 mg/L; p = .022) and lower DKK-1 levels (M = 4465 ng/L vs. 12,593). The presence of 1q21 gain was associated with higher levels of TK (M = 100.0 vs. 11.0 IU/L, p = .026) and lower levels of PINP (M = 49.3 vs. 67.4 mg/L, p = .030).

CONCLUSIONS

Our analysis has shown, some cytogenetic changes, especially delRB1, t(14;16) and 1q21gain, which affect the components of the cytokine network in multiple myeloma.

摘要

目的

本研究旨在探讨多发性骨髓瘤(MM)患者血清骨代谢标志物和骨髓微环境与细胞遗传学变化的相关性。

方法

我们评估了 308 例患者的细胞遗传学变化,并将其与以下骨髓代谢水平相关联:胸苷激酶(TK)、β2-微球蛋白(b-2-m)、Dickkopf-1 蛋白(DKK-1)、I 型胶原 C 端肽(ICTP)、I 型前胶原 N 端肽(PINP)、白细胞介素 6 受体(rIL-6)、血管细胞黏附分子-1(VCAM)、可溶性细胞间黏附分子-1、骨保护素(OPG)、肝细胞生长因子(HGF)、血管内皮生长因子(VEGF)、黏附素-1(SYN-1)和 Fas 抗原。

结果

delRB1 个体的 OPG 水平较低(M=7.39 vs. 5.46 pmol/L,p=.025),VEGF 水平较低(M=304 vs. 196 pg/ml;p=.036)。t(14;16)与较高的β2m 水平相关(M=7.59 vs. 4.13 mg/L;p=.022),与较低的 DKK-1 水平相关(M=4465 ng/L vs. 12593)。1q21 获得与较高的 TK 水平相关(M=100.0 vs. 11.0 IU/L,p=.026),与较低的 PINP 水平相关(M=49.3 vs. 67.4 mg/L,p=.030)。

结论

我们的分析表明,某些细胞遗传学变化,特别是 delRB1、t(14;16)和 1q21 获得,影响多发性骨髓瘤中细胞因子网络的组成部分。

相似文献

1
Bone metabolism parameters and their relation to cytogenetics in multiple myeloma.多发性骨髓瘤的骨代谢参数及其与细胞遗传学的关系。
Eur J Haematol. 2022 Jul;109(1):75-82. doi: 10.1111/ejh.13771. Epub 2022 Mar 24.
2
The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma.血清中选定生物学参数水平在多发性骨髓瘤的诊断、分期和预后中的重要性。
Neoplasma. 2010;57(2):102-10. doi: 10.4149/neo_2010_02_102.
3
[Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma].[沙利度胺对难治性及复发性多发性骨髓瘤骨髓微环境的影响]
Ai Zheng. 2003 Apr;22(4):346-9.
4
Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.多发性骨髓瘤骨髓微环境中Syndecan-1的上调与血管生成相关。
Eur J Haematol. 2015 Sep;95(3):211-7. doi: 10.1111/ejh.12473. Epub 2015 Jan 7.
5
The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myeloma.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):61-4. doi: 10.5507/bp.2008.009.
6
Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).多发性骨髓瘤中骨代谢的血清标志物:I型胶原羧基末端肽(ICTP)的预后价值。北欧骨髓瘤研究组(NMSG)。
Br J Haematol. 1997 Jan;96(1):103-10. doi: 10.1046/j.1365-2141.1997.8672495.x.
7
[The comparison of serum levels of selected biomarkers in monoclonal gammopathy of undetermined significance and multiple myeloma].意义未明的单克隆丙种球蛋白病与多发性骨髓瘤中选定生物标志物血清水平的比较
Cas Lek Cesk. 2009;148(7):315-22.
8
Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis.艾拉莫德对类风湿关节炎患者骨重塑循环调节因子水平及骨重塑标志物的影响。
Clin Rheumatol. 2017 Jun;36(6):1369-1377. doi: 10.1007/s10067-017-3668-8. Epub 2017 May 4.
9
Circulating angiogenic cytokines in multiple myeloma and related disorders.多发性骨髓瘤及相关疾病中的循环血管生成细胞因子
Eur Cytokine Netw. 2003 Jan-Mar;14(1):40-51.
10
Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma.意义未明的单克隆丙种球蛋白病(MGUS)和多发性骨髓瘤中的骨吸收参数[I型胶原羧基末端肽(ICTP)、I型胶原氨基末端肽(NTx)和脱氧吡啶啉(Dpd)]
Eur J Haematol. 2002 Jul;69(1):37-42. doi: 10.1034/j.1600-0609.2002.00505.x.

引用本文的文献

1
The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients.初诊多发性骨髓瘤患者血清骨代谢指标与骨病及生存的相关性。
Cancer Biol Ther. 2024 Dec 31;25(1):2403205. doi: 10.1080/15384047.2024.2403205. Epub 2024 Sep 18.
2
The numerous facets of 1q21 in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review).1q21在多发性骨髓瘤中的多方面研究:发病机制、临床病理特征、预后及临床进展(综述)
Oncol Lett. 2024 Apr 9;27(6):258. doi: 10.3892/ol.2024.14391. eCollection 2024 Jun.
3
New diagnostic strategy for multiple myeloma: A review.
多发性骨髓瘤的新诊断策略:综述。
Medicine (Baltimore). 2023 Dec 29;102(52):e36660. doi: 10.1097/MD.0000000000036660.